CAH vs REFR · P/E 35, rev $254.25B vs rev $222.7K
Cardinal Health Inc (CAH) versus Research Frontiers Incorporated (REFR) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Research Frontiers Incorporated (REFR) is a electronic components company listed on NASDAQ.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported REFR revenue for 2026-06-30 was $222.7K. Net income was -$1.2M. Revenue was up 63.3% from 2026-03-31 to 2026-06-30. REFR currently screens at market cap $22.4M.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. REFR currently screens at market cap $22.4M.
Not investment advice. Open the CAH and REFR stock pages for the full models.
Not investment advice.